{"cache_age":"3600","width":"920","description":"Cure First is tackling neuroblastoma (NB), a childhood cancer for which survival is poor and current treatments are overshadowed by side effects. Despite this,  NB has not attracted the focus of the pharmaceutical industry. Recently we were able to establish patient-derived organoids and to apply high-throughput robotic tools to highlight drug sensitivities. We are now raising funds to finance an in vivo study which will help validate our findings and prepare them for a clinical trial.","html":"<iframe src='https:\/\/www.globalgiving.org\/dy\/v2\/oembed\/?format=html&url=https%3A%2F%2Fwww.globalgiving.org%2Fprojects%2Fin-vivo-validation-for-neuroblastoma%2F' style='width:920px;height:613px;border:0;'><\/iframe>","type":"rich","title":"Pursuing new treatments for Neuroblastoma children on GlobalGiving","thumbnail_url":"https:\/\/www.globalgiving.org\/pfil\/19809\/pict_large.jpg","version":"1.0","height":"613"}